The Journal of Experimental Medicine · 2008 · 187 citations · 27 references
Life SciencesGeneticsMolecular GeneticsCell SignalingImmunogeneticsMedical GeneticsPulmonary InflammationPulmonary PathologyRespiratory Distress SyndromeRespiratory PathologyPulmonary Surfactant PhysiologySurfactant Dysfunction DisordersSurfactant FunctionSurfactant Protein DeficiencySurfactant Systems
Pulmonary alveolar proteinosis (PAP) is a rare lung disorder in which surfactant-derived lipoproteins accumulate excessively within pulmonary alveoli, causing severe respiratory distress. The importance of granulocyte/macrophage colony-stimulating factor (GM-CSF) in the pathogenesis of PAP has been confirmed in humans and mice, wherein GM-CSF signaling is required for pulmonary alveolar macrophage catabolism of surfactant. PAP is caused by disruption of GM-CSF signaling in these cells, and is usually caused by neutralizing autoantibodies to GM-CSF or is secondary to other underlying diseases. Rarely, genetic defects in surfactant proteins or the common beta chain for the GM-CSF receptor (GM-CSFR) are causal. Using a combination of cellular, molecular, and genomic approaches, we provide the first evidence that PAP can result from a genetic deficiency of the GM-CSFR alpha chain, encoded in the X-chromosome pseudoautosomal region 1.
27
Pulmonary Alveolar Proteinosis
Samuel H. Rosen, Benjamin Castleman, Averill A. Liebow et al. · New England Journal of Medicine · 1958 · 1.2K citations
Edouard G. Stanley, Graham J. Lieschke, D Grail et al. · Proceedings of the National Academy of Sciences · 1994 · 884 citations
Life Sciences, Immunology, Pathology +14
Kazuhiro Hayashida, Toshio Kitamura, D M Gorman et al. · Proceedings of the National Academy of Sciences · 1990 · 640 citations